Strategic Growth Recent leadership additions including General Counsel and VP of Quality signal a push to scale governance and compliance as the business expands in both the US and Sweden, presenting opportunities to position Sever Pharma Solutions as a trusted CDMO partner for regulated and high-potency projects.

Global Footprint Facilities in Malmö and Putnam coupled with a focus on controlled-release and high-potent drug delivery create cross-border collaboration prospects for clients seeking regional manufacturing, regulatory alignment, and dual-site supply continuity.

Regulatory Excellence ISO 9001 heritage and cGMP capabilities for clinical and commercial supplies position SPS as a quality-led partner for complex formulations such as oral tablets, transdermal films, implants, and drug-eluting devices, appealing to sponsors needing robust compliance from development through scale-up.

Early-Stage to Scale End-to-end services spanning formulation development, feasibility, process development, scale-up, and validation align with sponsors looking to de-risk early development and accelerate GMP manufacturing for clinical and commercial programs.

Collaborative Opportunities Active collaboration history with Silo Pharma on ketamine implants and involvement in DCAT Week indicates openness to strategic partnerships and long-term CDMO collaborations with specialty delivery platforms targeting high-potency or niche markets.